Fibromyalgia Syndrome and Attention Deficit Hyperactivity Disorder: Is There a Comorbidity and Are There Consequences for the Therapy of Fibromyalgia Syndrome?
- 16 January 1998
- journal article
- Published by The Haworth Press in Journal of Musculoskeletal Pain
- Vol. 6 (4) , 111-116
- https://doi.org/10.1300/j094v06n04_10
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- P.6.030 Use of MAO-A inhibitor moclobemide in fibromyalgia syndrome — first clinical resultsEuropean Neuropsychopharmacology, 1997
- The Hypothalamic-Pituitary-Adrenal Stress Axis in the Fibromyalgia SyndromeJournal of Musculoskeletal Pain, 1996
- Neurochemical Pathogenesis of Fibromyalgia SyndromeJournal of Musculoskeletal Pain, 1996
- A Clinical Overview of the Fibromyalgia SyndromeJournal of Musculoskeletal Pain, 1996
- Pharmacotherapy of Adult Attention Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, 1995
- The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]American Journal of Psychiatry, 1993
- Use of moclobemide in children with attention deficit hyperactivity disorderPsychopharmacology, 1992
- Psychiatric Status of Hyperactives as Adults: A Controlled Prospective 15-Year Follow-up of 63 Hyperactive ChildrenJournal of the American Academy of Child Psychiatry, 1985
- Hyperactives as young adults: Past and current substance abuse and antisocial behavior.Australian and New Zealand Journal of Surgery, 1984
- Serotonin concentrations in whole blood of hyperactive childrenThe Journal of Pediatrics, 1971